Targeting the mitotic kinase NEK2 enhances CDK4/6 inhibitor efficacy by potentiating genome instability - Jessica R. Bobbitt; Leslie Cuellar-Vite; Kristen L. Weber-Bonk; Marlee R. Yancey; Parth R. Majmudar; Ruth A. Keri (Journal of Biological Chemistry, 2025)